97 related articles for article (PubMed ID: 36550235)
1. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon DY; Nam D; Han Y; Kim DK; Kim G; Kim D; Bae J; Back S; Mun DG; Madar IH; Lee H; Kim SJ; Kim H; Hyun S; Kim CR; Choi SA; Kim YR; Jeong J; Jeon S; Choo YW; Lee KB; Kwon W; Choi S; Goo T; Park T; Suh YA; Kim H; Ku JL; Kim MS; Paek E; Park D; Jung K; Baek SH; Jang JY; Hwang D; Lee SW
Nat Cancer; 2023 Feb; 4(2):290-307. PubMed ID: 36550235
[TBL] [Abstract][Full Text] [Related]
2. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Brunton H; Caligiuri G; Cunningham R; Upstill-Goddard R; Bailey UM; Garner IM; Nourse C; Dreyer S; Jones M; Moran-Jones K; Wright DW; Paulus-Hock V; Nixon C; Thomson G; Jamieson NB; McGregor GA; Evers L; McKay CJ; Gulati A; Brough R; Bajrami I; Pettitt SJ; Dziubinski ML; Barry ST; Grützmann R; Brown R; Curry E; ; ; Pajic M; Musgrove EA; Petersen GM; Shanks E; Ashworth A; Crawford HC; Simeone DM; Froeling FEM; Lord CJ; Mukhopadhyay D; Pilarsky C; Grimmond SE; Morton JP; Sansom OJ; Chang DK; Bailey PJ; Biankin AV
Cell Rep; 2020 May; 31(6):107625. PubMed ID: 32402285
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Zhang Y; Fu F; Zhang Q; Li L; Liu H; Deng C; Xue Q; Zhao Y; Sun W; Han H; Gao Z; Guo C; Zheng Q; Hu H; Sun Y; Li Y; Ding C; Chen H
Cell Rep Med; 2024 Jan; 5(1):101358. PubMed ID: 38183982
[TBL] [Abstract][Full Text] [Related]
4. Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues.
Vallés-Martí A; de Goeij-de Haas RR; Henneman AA; Piersma SR; Pham TV; Knol JC; Verheij J; Dijk F; Halfwerk H; Giovannetti E; Jiménez CR; Bijlsma MF
Mol Oncol; 2024 Apr; ():. PubMed ID: 38650175
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
Bateman NW; Abulez T; Soltis AR; McPherson A; Choi S; Garsed DW; Pandey A; Tian C; Hood BL; Conrads KA; Teng PN; Oliver J; Gist G; Mitchell D; Litzi TJ; Tarney CM; Crothers BA; Mhawech-Fauceglia P; Dalgard CL; Wilkerson MD; Pierobon M; Petricoin EF; Yan C; Meerzaman D; Bodelon C; Wentzensen N; Lee JSH; ; Huntsman DG; Shah S; Shriver CD; Phippen NT; Darcy KM; Bowtell DDL; Conrads TP; Maxwell GL
NPJ Precis Oncol; 2024 May; 8(1):97. PubMed ID: 38710993
[No Abstract] [Full Text] [Related]
6. Proteogenomic analysis of human pancreatic ductal adenocarcinoma.
Nat Cancer; 2023 Feb; 4(2):163-164. PubMed ID: 36646857
[No Abstract] [Full Text] [Related]
7. What can Ribo-seq and proteomics tell us about the non-canonical proteome?
Prensner JR; Abelin JG; Kok LW; Clauser KR; Mudge JM; Ruiz-Orera J; Bassani-Sternberg M; Deutsch EW; van Heesch S
bioRxiv; 2023 May; ():. PubMed ID: 37292611
[TBL] [Abstract][Full Text] [Related]
8. FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.
Canel M; Sławińska AD; Lonergan DW; Kallor AA; Upstill-Goddard R; Davidson C; von Kriegsheim A; Biankin AV; Byron A; Alfaro J; Serrels A
Gut; 2023 Dec; 73(1):131-155. PubMed ID: 36977556
[TBL] [Abstract][Full Text] [Related]
9. Current status of molecular diagnostic approaches using liquid biopsy.
Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
[TBL] [Abstract][Full Text] [Related]
10. Increased glucose availability sensitizes pancreatic cancer to chemotherapy.
Vaziri-Gohar A; Hue JJ; Abbas A; Graor HJ; Hajihassani O; Zarei M; Titomihelakis G; Feczko J; Rathore M; Chelstowska S; Loftus AW; Wang R; Zarei M; Goudarzi M; Zhang R; Willard B; Zhang L; Kresak A; Willis JE; Wang GM; Tatsuoka C; Salvino JM; Bederman I; Brunengraber H; Lyssiotis CA; Brody JR; Winter JM
Nat Commun; 2023 Jun; 14(1):3823. PubMed ID: 37380658
[TBL] [Abstract][Full Text] [Related]
11. Performance comparison between multi-center histopathology datasets of a weakly-supervised deep learning model for pancreatic ductal adenocarcinoma detection.
Carrillo-Perez F; Ortuno FM; Börjesson A; Rojas I; Herrera LJ
Cancer Imaging; 2023 Jun; 23(1):66. PubMed ID: 37365659
[TBL] [Abstract][Full Text] [Related]
12. Integrated glycoproteomic characterization of clear cell renal cell carcinoma.
Lih TM; Cho KC; Schnaubelt M; Hu Y; Zhang H
Cell Rep; 2023 May; 42(5):112409. PubMed ID: 37074911
[TBL] [Abstract][Full Text] [Related]
13. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
Ravi A; Hellmann MD; Arniella MB; Holton M; Freeman SS; Naranbhai V; Stewart C; Leshchiner I; Kim J; Akiyama Y; Griffin AT; Vokes NI; Sakhi M; Kamesan V; Rizvi H; Ricciuti B; Forde PM; Anagnostou V; Riess JW; Gibbons DL; Pennell NA; Velcheti V; Digumarthy SR; Mino-Kenudson M; Califano A; Heymach JV; Herbst RS; Brahmer JR; Schalper KA; Velculescu VE; Henick BS; Rizvi N; Jänne PA; Awad MM; Chow A; Greenbaum BD; Luksza M; Shaw AT; Wolchok J; Hacohen N; Getz G; Gainor JF
Nat Genet; 2023 May; 55(5):807-819. PubMed ID: 37024582
[TBL] [Abstract][Full Text] [Related]
14. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.
Shi W; Wang Y; Xu C; Li Y; Ge S; Bai B; Zhang K; Wang Y; Zheng N; Wang J; Wang S; Ji G; Li J; Nie Y; Liang W; Wu X; Cui J; Wang Y; Chen L; Zhao Q; Shen L; He F; Qin J; Ding C
Nat Commun; 2023 Feb; 14(1):835. PubMed ID: 36788224
[TBL] [Abstract][Full Text] [Related]
15. Role of epigenetics in pancreatic ductal adenocarcinoma.
Pandey S; Gupta VK; Lavania SP
Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon DY; Nam D; Han Y; Kim DK; Kim G; Kim D; Bae J; Back S; Mun DG; Madar IH; Lee H; Kim SJ; Kim H; Hyun S; Kim CR; Choi SA; Kim YR; Jeong J; Jeon S; Choo YW; Lee KB; Kwon W; Choi S; Goo T; Park T; Suh YA; Kim H; Ku JL; Kim MS; Paek E; Park D; Jung K; Baek SH; Jang JY; Hwang D; Lee SW
Nat Cancer; 2023 May; 4(5):774. PubMed ID: 37208505
[No Abstract] [Full Text] [Related]
17. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma.
Murthy D; Attri KS
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108468
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
Ogunleye AO; Nimmakayala RK; Batra SK; Ponnusamy MP
Stem Cells; 2023 May; 41(5):417-430. PubMed ID: 36869789
[TBL] [Abstract][Full Text] [Related]
19. Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition.
Panagi M; Mpekris F; Voutouri C; Hadjigeorgiou AG; Symeonidou C; Porfyriou E; Michael C; Stylianou A; Martin JD; Cabral H; Constantinidou A; Stylianopoulos T
Clin Cancer Res; 2024 Jun; 30(11):2582-2597. PubMed ID: 38578281
[TBL] [Abstract][Full Text] [Related]
20. Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma.
Savage SR; Wang Y; Chen L; Jewell S; Newton C; Dou Y; Li QK; Bathe OF; Robles AI; Omenn GS; Thiagarajan M; Zhang H; Hostetter G; Zhang B
Clin Proteomics; 2024 Jan; 21(1):7. PubMed ID: 38291365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
